Biotechnology Reports

As biotechnology continues advancing at a rapid pace, insights from market research and consulting partners will remain vital in navigating industry transformation, competitor threats, regulatory shifts, and new product launches. The future outlook for biotech consulting services is very strong as clients demand strategic guidance exploring the next wave of biomedical, agricultural, and industrial innovations.

Report cover

CRISPR Gene Editing Market

CRISPR Gene Editing Market, By Product Type (Vector-based CRISPR products, DNA-free CRISPR products, Gene drive CRISPR products, Others), By Application (Biomedical applications, Agricultural applications, Industrial applications, Basic research, Others), By End-User (Pharmaceutical and biopharmaceutical companies, Academic and government research institutes, Contract research organizations, Biotechnology companies, Others), By Delivery Mode (Ex vivo, In vivo, Others), By Technology (CRISPR/Cas9, CRISPR/Cpf1 (Cas12a), Other CRISPR systems), By Service Type (Gene engineering design, Genomic screening, Other services), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Caribou Biosciences
Report cover

Stem Cell Therapy Market

Stem Cell Therapy Market, By Source (Embryonic Stem Cells Induced Pluripotent Stem Cells Adult Stem Cells Umbilical Cord Stem Cells Others), By Type (Allogeneic Stem Cell Therapy Autologous Stem Cell Therapy Syngeneic Stem Cell Therapy), By Application (Musculoskeletal Disorders Cardiovascular Diseases Neurological Disorders Autoimmune Diseases Oncology Wounds and Injuries Others), By Technology (Cell Acquisition Cell Production Cryopreservation Expansion and Sub-Culture Others), By End User (Hospitals and Clinics Academic and Research Institutes Biotechnology and Pharmaceutical Companies Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Mesoblast Limited, Osiris Therapeutics, Inc, MEDIPOST Co. Ltd, Holostem Terapie Avanzate S.r.l.
Report cover

Inherited Retinal Disease Market

Inherited Retinal Disease Market, By Disease Type (Retinitis Pigmentosa, Stargardt Disease, Leber Congenital Amaurosis, Usher Syndrome, Cone-Rod Dystrophy, Others), By Gene Mutation (RPE65 Mutation, ABCA4 Mutation, USH2A Mutation, RPGR Mutation, CNGA3 Mutation, CNGB3 Mutation, Others), By Treatment Type (Gene Therapy, Stem Cell Therapy, Nutritional Supplements, Low-Vision Aids, Others), By Route of Administration (Intravitreal, Subretinal, Intravenous, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes), By Distribution Channel (Direct Tenders, Retail Sales, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Spark Therapeutics (Novartis), ProQR Therapeutics, AGTC, Nightstar Therapeutics (Biogen)
Report cover

Natural Killer Cells Market

Natural Killer Cells Market, By Source (NK-92 Cell Line, Peripheral Blood NK Cells, Umbilical Cord Blood NK Cells, iPSC-derived NK Cells, Embryonic Stem Cell-derived NK Cells), By Type (Cytokine-Induced Killer Cells, Tumor-Infiltrating NK Cells, Allogeneic NK Cells, Autologous NK Cells), By Application (Cancer Immunotherapy, Infectious Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals, Research Institutes, Pharmaceutical Companies, Biotech Companies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2024-2031
  • date_range Base Year:  2023
  • apartment Key Players:  Fate Therapeutics, Affimed N.V., Glycostem Therapeutics, Kiadis Pharma, Innate Pharma
Report cover

Monoclonal Antibodies Market

Global Monoclonal Antibodies Market, Treatment Type (Biologics, Biosimilar, Others), Therapy Area (Oncology, Neurological Diseases, Cardiovascular Diseases, Infectious Diseases, Musculoskeletal Diseases, Hematologic Diseases, Others), Route of Administration (Oral, Injectable, Others), Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2023-2030
  • date_range Base Year:  2022
  • apartment Key Players:  Roche, Pfizer, AstraZeneca, Novartis, Bayer
Report cover

Human Recombinant Insulin Market

Global Human Recombinant Insulin Market, Product Type (Rapid-Acting Human Insulin, Short-Acting Human Insulin, Intermediate-Acting Human Insulin, Long-Acting Human Insulin, Premixed Human Insulin), Brand Product (Humalog, Novolog, Apidra, Humulin R, Novolin R, Humulin N, Novolin N, Levemir, Lantus, Humalog Mix, Novolog Mix, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More

  • calendar_month Study Period:  2023-2030
  • date_range Base Year:  2022
  • apartment Key Players:  Novo Nordisk, Eli Lilly, Biocon Ltd, and Sanofi